received substantial attention in recent years. The use of the MGFs as primary prophylaxis to prevent febrile neutropenia (FN … formulations of MGFs for primary and secondary prophylaxis of chemotherapy-induced neutropenia. Abstract: Methods:Methods: A …

Background and Objective:Background and Objective: Febrile neutropenia (FN) is a potentially life-threatening condition …

of neutropenia and reduces the incidence of febrile neutropenia after cancer chemotherapy. However, the use of G …-CSFs, particularly filgrastim, to treat established neutropenia remains controversial. A recent meta-analysis of randomised controlled … trials (RCTs) evaluating G-CSF treatment for established febrile neutropenia demonstrated a reduction in prolonged …

-CSF (pegfilgrastim) have been shown to reduce the severity and duration of chemotherapy-associated febrile neutropenia (FN) when …

the prevention and treatment of chemotherapy-induced febrile neutropenia has resulted in a number of pharmacoeconomic … evaluations was carried out. The focus of the review was prophylaxis and therapy of chemotherapy-induced neutropenia in patients …-CSF. In the treatment of established chemotherapy-induced febrile neutropenia, cost savings were found in all studies. This …

accelerated recovery from neutropenia. The clinical benefits included reductions in infections, anti-infective therapy and length …

Febrile neutropenia is a condition that can develop in patients with cancer following the administration of … Gram-negative microorganisms. Over the past 25 years, febrile neutropenia has changed from a condition that was fatal in … economic data on the empirical treatment of febrile neutropenia in patients with cancer. Therefore, there is a definite need to …

Neutropenic patients with cancer are at risk of serious infection, particularly if neutropenia is severe or prolonged …. Because patients with neutropenia have a diminished inflammatory response, fever is sometimes the first, and only, sign of … reported in trials of patients with febrile neutropenia. Meropenem can be used effectively as monotherapy in the first …

Objective: Patients with cancer-associated neutropenia are at high risk of developing severe infections which can be …-containing antibacterial regimens for the treatment of febrile neutropenia in patients with acute leukaemia. Design and setting: A …